JPH0782133A - Cosmetic - Google Patents

Cosmetic

Info

Publication number
JPH0782133A
JPH0782133A JP5229235A JP22923593A JPH0782133A JP H0782133 A JPH0782133 A JP H0782133A JP 5229235 A JP5229235 A JP 5229235A JP 22923593 A JP22923593 A JP 22923593A JP H0782133 A JPH0782133 A JP H0782133A
Authority
JP
Japan
Prior art keywords
production example
extract
cosmetic
ethanol
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5229235A
Other languages
Japanese (ja)
Other versions
JP3487617B2 (en
Inventor
Tsuneo Nanba
恒雄 難波
Yukio Hattori
征雄 服部
Kenji Shimomura
健次 下村
Yoshiyo Nakatani
佳代 中谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mikimoto Pharmaceutical Co Ltd
Original Assignee
Mikimoto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mikimoto Pharmaceutical Co Ltd filed Critical Mikimoto Pharmaceutical Co Ltd
Priority to JP22923593A priority Critical patent/JP3487617B2/en
Publication of JPH0782133A publication Critical patent/JPH0782133A/en
Application granted granted Critical
Publication of JP3487617B2 publication Critical patent/JP3487617B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PURPOSE:To obtain a cosmetic, having a good beautifying bleaching effect, which is demonstrated to have a long-term safety to human, since it is used as an internal or external medicine for years. CONSTITUTION:A cosmetic containing at least one solvent extract selected from the group consisting of Cymbopogen nardus, Desmodium gangeticum, Cardiospermum halicacabum, Muraya Koenigii and Smilax zeylanica.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は美白作用が高く、安全性
の高い化粧品に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a cosmetic having a high whitening effect and a high safety.

【0002】[0002]

【従来の技術】コウスイガヤ(Cymbopogon nardus)は
単子葉植物網、いね目、イネ科、オガルカヤ属の植物で
蚊の防虫剤、香料、石鹸の原料とされ南アフリカでは駆
虫剤、風邪の治療薬、解熱剤に使われている。
2. Description of the Related Art Cymbopogon nardus is a monocotyledonous net, a plant of the genus Poaceae, Poaceae, and Ogarkaya, which is used as a raw material for mosquito repellents, fragrances, and soaps. Is used for.

【0003】デスモディウム ガンゲチクム(Desmodiu
m gangeticum)は双子葉植物網、離弁花亜網、ばら目、
マメ科、ヌスビトハギ属の植物で、無月経、腹痛、治療
薬として用いられている。
Desmodiu
m gangeticum) is a dicotyledonous net, a leaflet subweb, a rose,
It is a plant of the genus Leguminus and genus Nebula, and is used as a therapeutic agent for amenorrhea, abdominal pain.

【0004】フウセンカズラ(Cardiospermum halicaca
bum)は双子葉植物網、離弁花亜網、むくろじ目、ムク
ロジ科、フウセンカズラ属の植物で南アフリカ原産のつ
る性の1年草であるが本来は多年草で黄疸、淋病、疱
疹、蛇の咬傷などの治療薬に用いられてきた。
[0004] Cardiospermum halicaca
bum) is a plant of dicotyledonous net, leaf-seed sub net, sorghum, syringaceae, phyllanthaceae, which is a vine annual plant native to South Africa, but originally a perennial jaundice, gonorrhea, herpes, snake bite. It has been used as a therapeutic drug.

【0005】ムラヤ コエニギイ(Murraya koenigii)
は双子葉植物網、離弁花亜網、ふうろそう目、ミカン科
の植物でインドやスリランカに分布し、乾燥した低地に
普遍的に見られる。薬用としては便秘、腹疝痛、下痢等
に用いられてきた。
Muraya koenigii
Is a dicotyledonous net, a leaflet subnet, a dwarf eye, and a citrus family plant distributed in India and Sri Lanka, and is commonly found in arid lowlands. As a medicinal substance, it has been used for constipation, abdominal colic, diarrhea, etc.

【0006】スミラックス ゼイラニカ(Smilax zeyla
nica)は単子葉植物網、ゆり目、ユリ科、シオデ属の植
物で性病、赤痢、リウマチの治療薬として利用されてい
た。
[0006] Smilax zeyla
nica) was used as a remedy for sexually transmitted diseases, dysentery, and rheumatism in monocotyledonous nets, lilicaceae, Liliaceae, and Shiode plants.

【0007】一方、化粧料の原料として使用できる美白
作用のある物質としては種々の物質が知られているが、
合成品は、長期間人間の肌に適用した場合の安全性の保
証がなく、使用が制限されつつある。一方、天然物では
美白作用が弱いものが多い。しかし人の肌に対する安全
性の面から天然物で、多年、人が食したりして、安全性
の面で保証されており、しかも美白作用が強く、更に皮
膚に対する他の効果も合せてもつ物質が望まれていた。
On the other hand, various substances are known as substances having a whitening effect which can be used as a raw material for cosmetics.
Synthetic products do not guarantee safety when applied to human skin for a long period of time, and their use is being limited. On the other hand, many natural products have a weak whitening effect. However, it is a natural product from the viewpoint of safety for human skin, and has been guaranteed for safety by people eating it for many years. Moreover, it has a strong whitening effect and also has other effects on the skin. Was desired.

【0008】[0008]

【発明が解決しようとする課題】本発明の目的は、皮膚
に適用して安全であると共に、美白作用が大きく且つ安
全性に優れている化粧料を得ることである。
An object of the present invention is to obtain a cosmetic which is safe when applied to the skin, has a large whitening effect and is excellent in safety.

【0009】[0009]

【課題を解決するための手段】本発明者らは、前記の課
題を解決するため、すでに多年にわたって食用に供さ
れ、人体に対する安全性が確認されている植物をスクリ
ーニングして調べ、化粧品として利用価値のあるものを
検討した。その結果、コウスイガヤ、デスモディウム
ガンゲチクム、フウセンカズラ、ムラヤ コエニギイ、
スミラックス ゼイラニカが非常に化粧品原料として、
或いは医薬部外品としての有効性を有することを見い出
した。
[Means for Solving the Problems] In order to solve the above problems, the present inventors screened and investigated plants that have been used for food for many years and confirmed to be safe for the human body, and used as cosmetics. Considered something of value. As a result, Kosugaiya, Desmodium
Gangechikum, Pleurotus cornucopiae, Muraya Coenigii,
Sumirax Zeiranika is a very cosmetic ingredient,
Alternatively, it has been found to be effective as a quasi drug.

【0010】すなわち本発明は、コウスイガヤ、デスモ
ディウム ガンゲチクム(Desmodium gangeticum)、フ
ウセンカズラ、ムラヤ コエニギイ(Murraya koenigi
i)、スミラックス ゼイラニカ(Smilax zeylanica)
よりなる群より選んだ少なくとも1種の溶媒抽出物を含
む化粧料である。
[0010] That is, the present invention, Kosuigaya, Desmodium gangeticum (Desmodium gangeticum), Pleurotus cornucopia, Muraya koenigi (Murraya koenigi)
i), Smilax zeylanica
A cosmetic comprising at least one solvent extract selected from the group consisting of:

【0011】これらの植物の利用方法としては、水或い
は親水性有機溶媒例えば、エタノール、メタノール、ア
セトン等で抽出する。しかしながら、化粧品原料の抽出
であるから、水或いはエタノール或いはこれの混合溶媒
での抽出が好ましいのは当然である。また、場合によっ
ては、グリセリン、1,3ブチレングリコール、プロピ
レングリコール等の多価アルコール又は多価アルコール
と水の混液も抽出に利用できる。またさらに凍結乾燥し
て粉体として利用することも利用方法によっては有効で
ある。
As a method of utilizing these plants, extraction is performed with water or a hydrophilic organic solvent such as ethanol, methanol or acetone. However, it is natural that extraction with water, ethanol, or a mixed solvent thereof is preferable since it is extraction of cosmetic raw materials. In some cases, a polyhydric alcohol such as glycerin, 1,3 butylene glycol, propylene glycol or the like or a mixed liquid of polyhydric alcohol and water can be used for extraction. Further, freeze-drying and using it as powder is also effective depending on the method of use.

【0012】この物質を他の化粧品原料例えばスクワラ
ン、ホホバ油等の液状油、ミツロウ、セチルアルコール
等の固体油、各種の活性剤、グリセリン、1,3ブチレ
ングリコール等の保湿剤や各種薬剤等を添加してさまざ
まな剤形の化粧料を調製することができる。例えばロー
ション、クリーム、乳液、パック等で目的に応じて利用
形態を考えればよい。
This substance may be used as other cosmetic raw materials such as liquid oils such as squalane and jojoba oil, solid oils such as beeswax and cetyl alcohol, various activators, moisturizers such as glycerin and 1,3 butylene glycol, and various agents. It can be added to prepare cosmetics in various dosage forms. For example, a lotion, a cream, a milky lotion, a pack, or the like may be used depending on the purpose.

【0013】[0013]

【実施例】以下に実際の利用方法である実施例を記載す
るが、本発明はこの実施例によって何ら限定されるもの
ではない。本発明で使用したコウスイガヤ、デスモディ
ウム ガンゲチクム、フウセンカズラ、ムラヤ コエニ
ギイ、スミラックス ゼイラニカの抽出物の製造例を次
に示す。
EXAMPLE An example of an actual usage will be described below, but the present invention is not limited to this example. The production examples of the extracts of Scutellaria japonicus, Desmodium gangechikum, Fusarium chinensis, Muraya Koenigii, and Sumirax zeilanica used in the present invention are shown below.

【0014】(製造例1)コウスイガヤの根茎(乾燥
品)を10gに50%エタノール300mlを加えて時々
撹拌しつつ5日間放置した。これを濾過後凍結乾燥し
た。
(Production Example 1) To 10 g of rhizome (dry product) of Spodoptera litura, was added 300 ml of 50% ethanol, and the mixture was left for 5 days with occasional stirring. This was filtered and freeze-dried.

【0015】(製造例2)デスモディウム ガンゲチク
ムの全草(乾燥品)を10gにエタノール300mlを加
えて時々撹拌しつつ5日間放置した。これを濾過後凍結
乾燥した。
(Production Example 2) To 10 g of the whole plant (desiccated) of Desmodium gangechicum was added 300 ml of ethanol, and the mixture was left for 5 days with occasional stirring. This was filtered and freeze-dried.

【0016】(製造例3)デスモディウム ガンゲチク
ムの全草(乾燥品)を10gに50%エタノール水溶液
300mlを加えて時々撹拌しつつ5日間放置した。これ
を濾過後凍結乾燥した。
(Production Example 3) To 10 g of whole grass (desiccated) of Desmodium gangechicum was added 300 ml of 50% ethanol aqueous solution, and the mixture was left for 5 days with occasional stirring. This was filtered and freeze-dried.

【0017】(製造例4)フウセンカズラの全草(乾燥
品)を10gに50%エタノール水溶液300mlを加え
て時々撹拌しつつ5日間放置した。これを濾過後凍結乾
燥した。
(Production Example 4) To 10 g of the whole plant (dry product) of Pleurotus cornucopiae was added 300 ml of a 50% aqueous ethanol solution, and the mixture was left for 5 days with occasional stirring. This was filtered and freeze-dried.

【0018】(製造例5)ムラヤ コエニギイの枝(乾
燥品)を10gにエタノール300mlを加えて時々撹拌
しつつ5日間放置した。これを濾過後凍結乾燥した。
(Production Example 5) To 10 g of Muraya Koenigii branch (dry product) was added 300 ml of ethanol, and the mixture was left for 5 days with occasional stirring. This was filtered and freeze-dried.

【0019】(製造例6)ムラヤ コエニギイの枝(乾
燥品)を10gに50%エタノール水溶液300mlを加
えて時々撹拌しつつ5日間放置した。これを濾過後凍結
乾燥した。
(Manufacturing Example 6) To 10 g of Muraya Koenigii branch (dried product) was added 300 ml of 50% aqueous ethanol solution, and the mixture was left for 5 days with occasional stirring. This was filtered and freeze-dried.

【0020】(製造例7)スミラックス ゼイラニカの
根(乾燥品)を10gにエタノール300mlを加えて時
々撹拌しつつ5日間放置した。これを濾過後凍結乾燥し
た。
(Production Example 7) To 10 g of the roots (dry product) of Smilax Zeylanica, 300 ml of ethanol was added, and the mixture was left for 5 days with occasional stirring. This was filtered and freeze-dried.

【0021】(製造例8)スミラックス ゼイラニカの
根(乾燥品)を10gに50%エタノール水溶液300
mlを加えて時々撹拌しつつ5日間放置した。これを濾過
後凍結乾燥した。
(Production Example 8) Smilax Zeylanica root (dry product) was added to 10 g of a 50% ethanol aqueous solution 300.
ml was added and left for 5 days with occasional stirring. This was filtered and freeze-dried.

【0022】 (実施例1)ローション (重量%) オリーブ油 0.5 製造例1の抽出物 0.5 ポリオキシエチレン(20E.O.)ソルビタンモノステアレート 2.0 ポリオキシエチレン(60E.O.)硬化ヒマシ油 2.0 エタノール 10.0 1.0%ヒアルロン酸ナトリウム水溶液 5.0 精製水 80.0(Example 1) Lotion (% by weight) Olive oil 0.5 Extract of Production Example 1 0.5 Polyoxyethylene (20 E.O.) sorbitan monostearate 2.0 Polyoxyethylene (60 E.O. ) Hydrogenated castor oil 2.0 Ethanol 10.0 1.0% sodium hyaluronate aqueous solution 5.0 Purified water 80.0

【0023】 (実施例2)クリーム (重量%) A スクワラン 20.0 オリーブ油 2.0 ミンク油 1.0 ホホバ油 5.0 ミツロウ 5.0 セトステアリルアルコール 2.0 グリセリンモノステアレート 1.0 ソルビタンモノステアレート 2.0 製造例2の抽出物 1.0 B 精製水 47.9 ポリオキシエチレン(20E.O.)ソルビタンモノステアレート 2.0 ポリオキシエチレン(60E.O.)硬化ヒマシ油 1.0 グリセリン 5.0 1.0%ヒアルロン酸ナトリウム水溶液 5.0 パラオキシ安息香酸メチル 0.1 AとBをそれぞれ計量し、70℃まで加温し、BにAを
撹拌しつつ徐々に加えたのち、ゆっくり撹拌しつつ30
℃まで冷却した。
Example 2 Cream (wt%) A Squalane 20.0 Olive oil 2.0 Mink oil 1.0 Jojoba oil 5.0 Beeswax 5.0 Cetostearyl alcohol 2.0 Glycerin monostearate 1.0 Sorbitan Monostearate 2.0 Extract of Production Example 2 1.0 B Purified water 47.9 Polyoxyethylene (20 E.O.) sorbitan monostearate 2.0 Polyoxyethylene (60 E.O.) hydrogenated castor oil 1 0.0 Glycerin 5.0 1.0% sodium hyaluronate aqueous solution 5.0 Methyl paraoxybenzoate 0.1 A and B were weighed and heated to 70 ° C., and A was gradually added to B while stirring. After that, while stirring slowly, 30
Cooled to ° C.

【0024】(実施例3)実施例1の製造例1の抽出物
を製造例3の抽出物に変え作成したローション。
Example 3 A lotion prepared by replacing the extract of Production Example 1 of Example 1 with the extract of Production Example 3.

【0025】(実施例4)実施例2の製造例2の抽出物
を製造例4の抽出物に変え作成したクリーム。
(Example 4) A cream prepared by replacing the extract of Production Example 2 of Example 2 with the extract of Production Example 4.

【0026】(実施例5)実施例1の製造例1の抽出物
を製造例5の抽出物に変え作成したローション。
Example 5 A lotion prepared by replacing the extract of Production Example 1 of Example 1 with the extract of Production Example 5.

【0027】(実施例6)実施例2の製造例2の抽出物
を製造例6の抽出物に変え作成したクリーム。
(Example 6) A cream prepared by changing the extract of Production Example 2 of Example 2 into the extract of Production Example 6.

【0028】(実施例7)実施例1の製造例1の抽出物
を製造例7の抽出物に変え作成したローション。
(Example 7) A lotion prepared by changing the extract of Production Example 1 of Example 1 into the extract of Production Example 7.

【0029】(実施例8)実施例2の製造例2の抽出物
を製造例8の抽出物に変え作成したクリーム。
(Example 8) A cream prepared by replacing the extract of Production Example 2 of Example 2 with the extract of Production Example 8.

【0030】(チロシナーゼ活性阻害試験) (試験方法)マツクルバルン(Mcllvaln)緩衝液0.9
ml、1.66mMチロシン(Tyrosine)溶液1.0ml、前
記製造例(凍結乾燥品)の0.1wt/v%水溶液(溶解
しにくい場合はエタノールを加えて溶解したのち精製水
を加えて、エバポーレートし、エタノールを除去したの
ち、0.1wt/v%になるように調製した)1.0mlを
スクリューバイアルにとり、37℃恒温水槽中で5分以
上加温した。チロシナーゼ溶液(Sigma社製、マッシュ
ルーム由来、914ユニット/ml)0.1mlを加え、3
7℃恒温水槽中で保温し、10分後に475nmで吸光度
を測定した。対照として、上記試料液のかわりに純水を
加え同様に測定した。この試験では試料の終濃度は0.
033%となる。 (計算式) チロシナーゼ活性阻害率(%)={B−(A−P)}/
B×100 但し A:試料検体の吸光度 B:対照の吸光度 P:試料検体の着色による吸光度(3倍希釈) この結果を表1に示す。
(Tyrosinase activity inhibition test) (Test method) Mcllvaln buffer solution 0.9
ml, 1.66 mM Tyrosine solution 1.0 ml, 0.1 wt / v% aqueous solution of the above production example (freeze dried product) Then, after removing ethanol, 1.0 ml (prepared to have a concentration of 0.1 wt / v%) was placed in a screw vial and heated in a 37 ° C. constant temperature water bath for 5 minutes or more. Add 0.1 ml of tyrosinase solution (Sigma, mushroom-derived, 914 units / ml), and add 3
The temperature was kept in a constant temperature water bath at 7 ° C, and after 10 minutes, the absorbance was measured at 475 nm. As a control, pure water was added instead of the sample solution and the same measurement was performed. In this test, the final concentration of the sample was 0.
It will be 033%. (Calculation formula) Tyrosinase activity inhibition rate (%) = {B- (AP)} /
B × 100 However, A: Absorbance of sample specimen B: Absorbance of control P: Absorbance due to coloring of sample specimen (3-fold dilution) The results are shown in Table 1.

【0031】[0031]

【表1】 [Table 1]

【0032】(使用テスト)女性5名づつの顔面を左右
に分け、一方に実施例のローションとクリームをセット
にして施用してもらい、他方には比較例のローションと
クリームをセットにして使用してもらった。なお比較例
1は実施例1の製造例1の抽出物を水にかえたローショ
ン、比較例2は実施例2の製造例2の抽出物を水にかえ
たクリームである。毎日、1回以上使用してもらって、
3月後下記の判定基準により評点を出してもらった。な
お、20名を4班にわけ、下記の試料を使って実験し
た。
(Use test) The face of each of 5 women was divided into left and right, one of which had the lotion and cream of the example applied as a set, and the other of which had the lotion and cream of the comparative example set as a set and used. I got it. Comparative Example 1 is a lotion prepared by changing the extract of Production Example 1 of Example 1 into water, and Comparative Example 2 is a cream prepared by changing the extract of Production Example 2 of Example 2 in water. Have it used once or more every day,
Three months later, I got a score based on the following criteria. In addition, 20 people were divided into 4 groups and experimented using the following samples.

【0033】[0033]

【表2】 [Table 2]

【0034】判定基準は以下のようでこの評点の合計値
を表3に示す。 実施例の方が非常によい 3 実施例の方がかなりよい 2 実施例の方がややよい 1 差がない 0 比較例の方がややよい −1 比較例の方がかなりよい −2 比較例の方が非常によい −3
The judgment criteria are as follows, and the total value of these scores is shown in Table 3. Example is very good 3 Example is considerably good 2 Example is slightly good 1 No difference 0 Comparative example is good −1 Comparative example is good −2 Comparative example Is very good -3

【0035】[0035]

【表3】 [Table 3]

【0036】[0036]

【発明の効果】チロシナーゼ活性阻害試験結果より明ら
かなように、本発明の植物の溶媒抽出物は優れたチロシ
ナーゼ活性阻害効果を有する。使用テスト結果より見て
も、この抽出物を含む化粧料は含まない化粧料にくらべ
格段の美白作用が認められた。これら植物は長年にわた
り内用、外用薬として使用されて来ており、人体に対す
る長期安全性について保証されている。
As is apparent from the results of the tyrosinase activity inhibition test, the plant solvent extract of the present invention has an excellent tyrosinase activity inhibition effect. From the results of the use test, the whitening effect was remarkably higher than that of the cosmetics containing no extract. These plants have been used as internal and external medicines for many years, and their long-term safety for the human body is guaranteed.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 服部 征雄 富山県富山市五福末広町2556−4 2− 203 (72)発明者 下村 健次 三重県伊勢市船江3−16−32 (72)発明者 中谷 佳代 三重県度会郡御園村高向774−11 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Masao Hattori 2556-4-22-203 Gofukusuehiro-cho, Toyama City, Toyama Prefecture (72) Inventor Kenji Shimomura 3-16-32 Funae, Ise City, Mie Prefecture (72) Inventor Nakatani Kayo 774-11 Takamukai, Misono Village, Mie Prefecture

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 コウスイガヤ、デスモディウム ガンゲ
チクム(Desmodiumgangeticum)、フウセンカズラ、ム
ラヤ コエニギイ(Murraya koenigii)、スミラックス
ゼイラニカ(Smilax zeylanica)よりなる群より選ん
だ少なくとも1種の溶媒抽出物を含む化粧料。
1. A cosmetic containing at least one solvent extract selected from the group consisting of Kosuigaya, Desmodium gangeticum, Fusenkazura, Muraya koenigii, and Smilax zeylanica.
JP22923593A 1993-09-14 1993-09-14 Cosmetics Expired - Lifetime JP3487617B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP22923593A JP3487617B2 (en) 1993-09-14 1993-09-14 Cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22923593A JP3487617B2 (en) 1993-09-14 1993-09-14 Cosmetics

Publications (2)

Publication Number Publication Date
JPH0782133A true JPH0782133A (en) 1995-03-28
JP3487617B2 JP3487617B2 (en) 2004-01-19

Family

ID=16888950

Family Applications (1)

Application Number Title Priority Date Filing Date
JP22923593A Expired - Lifetime JP3487617B2 (en) 1993-09-14 1993-09-14 Cosmetics

Country Status (1)

Country Link
JP (1) JP3487617B2 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07138135A (en) * 1993-11-17 1995-05-30 Mikimoto Pharmaceut Co Ltd 5alpha-reductase inhibitor
JP2009215269A (en) * 2008-03-13 2009-09-24 Okinawa Pref Gov Tyrosinase activity inhibitor and skin-lightening cosmetic containing the same
JP2009298711A (en) * 2008-06-11 2009-12-24 Maruzen Pharmaceut Co Ltd Skin-lightening agent, and skin care preparation for external use and food and drink
WO2011144536A1 (en) * 2010-05-18 2011-11-24 Unilever Nv A personal care composition
JP2013014530A (en) * 2011-07-01 2013-01-24 Nippon Yakuyo Shokuhin Kenkyusho:Kk Whitening composition
KR101971679B1 (en) * 2017-10-19 2019-04-23 한국생명공학연구원 Tyrosinase inhibition and whitening activity of solvent extract of Desmodium sequax Wall or a fraction thereof

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07138135A (en) * 1993-11-17 1995-05-30 Mikimoto Pharmaceut Co Ltd 5alpha-reductase inhibitor
JP2009215269A (en) * 2008-03-13 2009-09-24 Okinawa Pref Gov Tyrosinase activity inhibitor and skin-lightening cosmetic containing the same
JP2009298711A (en) * 2008-06-11 2009-12-24 Maruzen Pharmaceut Co Ltd Skin-lightening agent, and skin care preparation for external use and food and drink
WO2011144536A1 (en) * 2010-05-18 2011-11-24 Unilever Nv A personal care composition
US9283170B2 (en) 2010-05-18 2016-03-15 Conopco, Inc. Personal care composition
EA023896B1 (en) * 2010-05-18 2016-07-29 Юнилевер Н.В. Skin lightening composition comprising an extract of desmodium gangeticum
JP2013014530A (en) * 2011-07-01 2013-01-24 Nippon Yakuyo Shokuhin Kenkyusho:Kk Whitening composition
KR101971679B1 (en) * 2017-10-19 2019-04-23 한국생명공학연구원 Tyrosinase inhibition and whitening activity of solvent extract of Desmodium sequax Wall or a fraction thereof
WO2019078662A3 (en) * 2017-10-19 2019-06-06 한국생명공학연구원 Tyrosinase inhibition and skin-whitening activity of desmodium sequax solvent extract or fraction thereof

Also Published As

Publication number Publication date
JP3487617B2 (en) 2004-01-19

Similar Documents

Publication Publication Date Title
JPH05320037A (en) Antioxidation agent
JP3268695B2 (en) Cosmetics
JPH05331041A (en) Beautifying cosmetic
KR20140071738A (en) Cosmetic composition for alleviating dermatitis and skin irritation
KR101078888B1 (en) A cosmetic composition comprising tissue cultured Echinaceae adventitious roots and an preparing method thereof
JP3647054B2 (en) Antioxidant
KR102300581B1 (en) Compositions for improving skin conditions comprising plant extracts or fractions thereof
JP2004067634A (en) Hair growing material and external preparation for skin containing the same
JPH0782133A (en) Cosmetic
KR940001125B1 (en) Thirosinase interfering drug composition containing chrysanthemum moriflium ramat extracts
KR102150927B1 (en) Cosmetic and pharmaceutical compositin comprising sasa quelpaertensis extract and urea
KR100530843B1 (en) Anti-inflammatory composition containing paecilomyces extract and cordyceps extracts as effective composition
JPH0687731A (en) Cosmetic
JP3541049B2 (en) Hyaluronidase inhibitor
JP6895860B2 (en) Slimming foods and topical compositions
KR101501538B1 (en) Composition for External Application to the Skin Using an Extract of Seeds of Opuntia ficus-indica var. saboten
KR20090126992A (en) Cosmetic application of defatted camellia japonica seed debris and seed coats and its extract
JP2007320970A (en) Cosmetic
JP3487619B2 (en) 5α-reductase inhibitor
KR20180102928A (en) A cosmetic composition for skin antiaging comprising an extract of Citrusfortunella microcarpa as an active ingredient
JPH0680553A (en) Hyaluronidase inhibitor
JPH05155750A (en) Cosmetic
KR102127771B1 (en) A composition for antioxidation, anti-inflammation, antiaging or skin soothing comprising herb complex extracts
JPH05124952A (en) Cosmetic
JPH07188045A (en) Antiplasmin agent

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121031

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121031

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131031

Year of fee payment: 10